Phenome Health is a 501(c)(3) organization, classified under Medical Research (NTEE H05). Contributions are tax-deductible.
2101 4Th Avenue, Seattle, WA 98121-2352
Among the 17 scored medical research organizations in Seattle, Phenome Health holds 2.4 months of operating reserves (peer median 5.5 months), runs a typical yearly surplus of 14.9% (peers: surplus of 1.3%), and has grown spending 39.9% a year (peers: grown spending 3.8% a year).
In fiscal year 2025 it reported $5,913,544 in revenue and $6,338,192 in expenses, with contributions making up 99.8% of revenue.
Phenome Health's mission is to develop the tools & insights that power data-driven personalized health. We envision a world where everyone is empowered by their own data to improve wellness and prevent disease.
Largest programs · fiscal year 2025
Predictive modeling. We continued the past years efforts to build computational models and the required bioinformatic pipelines for the purpose of modeling health trajectories for individuals given personal health data as inputs to models. All data are deidentified with no access to phi or pii by personnel working on the modeling efforts. In 2025, we added access to more public databases to inform… Read more
Predictive modeling. We continued the past years efforts to build computational models and the required bioinformatic pipelines for the purpose of modeling health trajectories for individuals given personal health data as inputs to models. All data are deidentified with no access to phi or pii by personnel working on the modeling efforts. In 2025, we added access to more public databases to inform our models as deliverables for our current federally funded projects.
$2,254,436 spent · 47.0% of program spending
Type 2 diabetes study. In 2025, we began logistical execution and study set-up of a type II diabetes study that we completed a pilot for in 2024. This study will enroll 1000 patients with diabetes, through clinical partnerships. The first recruited patient will enroll in 2026. The study is intended to dentify subtypes of type II diabetes through profiling blood samples, facilitating to more tailor… Read more
Type 2 diabetes study. In 2025, we began logistical execution and study set-up of a type II diabetes study that we completed a pilot for in 2024. This study will enroll 1000 patients with diabetes, through clinical partnerships. The first recruited patient will enroll in 2026. The study is intended to dentify subtypes of type II diabetes through profiling blood samples, facilitating to more tailored interventions in a sub-type specific manner.
$1,247,134 spent · 26.0% of program spending
Multiomic data platform build. In 2025 we continued to invest in building a computational environment capable of serving the need to ingest and analyze high dimensional health data. This platform requires continued feature development and maintenance. It is currently serving existing predictive modeling needs and will serve projects we secure funding for in the future.$1,295,101 spent · 27.0% of program spending
Pre-diabetes study. In addition to type II diabetes study, in 2025 we began analysis of a set of samples collected by a collaborator over 15 years that represent people-at-risk for diabetes but without a disease diagnosis at the time of enrollment. This study is designed to identify pre-diagnostic, sub-type specific markers in blood that could inform tailored prevention strategies beyond the stand… Read more
Pre-diabetes study. In addition to type II diabetes study, in 2025 we began analysis of a set of samples collected by a collaborator over 15 years that represent people-at-risk for diabetes but without a disease diagnosis at the time of enrollment. This study is designed to identify pre-diagnostic, sub-type specific markers in blood that could inform tailored prevention strategies beyond the standard current approaches.
Where each dollar went · fiscal year 2025
Of every dollar it spent, 76¢ went to programs, 11¢ to management and 13¢ to fundraising.
Programs $4,796,671
Management $686,724
Fundraising $854,797
In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.
Spending on programs Not scored; America's Best needs 65%+
76%
Meets
Compared with Seattle peers
Measure
This organization
Peer median
Operating reserves
2.4 mo
5.5 mo
Typical margin
+14.9%
+1.3%
Spending growth
+39.9% / yr
+3.8% / yr
Debt load
70.3%
25.3%
Peers: the 17 Seattle medical research organizations with a score, ranked or below the bar.
Tax filings by year
Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.
Revenue$5,913,544Fiscal year 2025
Expenses$6,338,192Fiscal year 2025
Total assets$4,325,941Fiscal year 2025
Total liabilities$3,040,227Fiscal year 2025
Fiscal year ending December2025
Revenue$5,913,544
Expenses$6,338,192
Net income−$424,648
Net assets$1,285,714
Notable sources of revenue
Percent of total revenue
Contributions
$5,901,830
99.8%
Program services
$0
0.0%
Investment income
$5,214
0.1%
Other (net)
$6,500
0.1%
Assets / debt
Total assets
$4,325,941
Total liabilities
$3,040,227
Net assets
$1,285,714
Compensation
Not in our extract for this year.
Fiscal year ending December2024
Revenue$3,516,875
Expenses$3,360,606
Net income$156,269
Net assets$1,710,362
Notable sources of revenue
Percent of total revenue
Contributions
$3,516,837
100.0%
Program services
$0
0.0%
Investment income
$24
0.0%
Other (net)
$14
0.0%
Assets / debt
Total assets
$2,377,749
Total liabilities
$667,387
Net assets
$1,710,362
Compensation
Not in our extract for this year.
Fiscal year ending December2023
Revenue$3,720,155
Expenses$2,974,159
Net income$745,996
Net assets$1,504,095
Notable sources of revenue
Percent of total revenue
Contributions
$3,719,541
100.0%
Program services
$0
0.0%
Investment income
$12
0.0%
Other (net)
$602
0.0%
Assets / debt
Total assets
$1,633,565
Total liabilities
$129,470
Net assets
$1,504,095
Compensation
Officers and key employees
$720,624
Share of expenses
24.2%
Fiscal year ending December2022
Revenue$3,072,624
Expenses$2,314,525
Net income$758,099
Net assets$758,099
Notable sources of revenue
Percent of total revenue
Contributions
$3,072,624
100.0%
Program services
$0
0.0%
Investment income
$0
0.0%
Other (net)
$0
0.0%
Assets / debt
Total assets
$942,596
Total liabilities
$184,497
Net assets
$758,099
Compensation
Officers and key employees
$890,749
Share of expenses
38.5%
About this data
Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?